Telomir Pharmaceuticals, Inc. Common Stock (TELO)

USD 4.67

(-4.89%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021
Total Assets 4.77 Million 48.73 Thousand -
Total Current Assets 435.22 Thousand 48.73 Thousand -
Cash And Short Term Investments 1231.00 1419.00 -
Cash and Cash Equivalents 1231.00 1419.00 -
Short Term Investments - - -
Net Receivables 130 Thousand - -
Inventory 303.28 Thousand - -
Other Current Assets 713.00 47.31 Thousand -
Total Non-Current Assets 4.33 Million 47.31 Thousand -
Net PPE - - -
Good Will And Intangible Assets - - -
Good Will - - -
Intangible Assets - - -
Long-Term Investments - - -
Tax Assets - - -
Other Non Current Assets 4.33 Million 47.31 Thousand -
Other Assets - -47.31 Thousand -
Total Liabilities 1.33 Million 986 Thousand 138.13 Thousand
Total Current Liabilities 1.33 Million 986 Thousand 138.13 Thousand
Account Payables 707.18 Thousand 404.22 Thousand 18.73 Thousand
Tax Payables - - -
Short Term Debt 101 Thousand 581.78 Thousand 119.39 Thousand
Deferred Revenue - -581.78 Thousand -119.39 Thousand
Other Current Liabilities 527.37 Thousand 581.78 Thousand 119.39 Thousand
Total Non Current Liabilities - - -
Long-Term Debt - - -
Deferred Revenue Non Current - - -
Deferred Tax Liabilities Non Current - - -
Other Non Current Liabilities - - -
Other Liabilities - - -
Total Equity 3.43 Million -937.27 Thousand -138.13 Thousand
Stock Holders Equity 3.43 Million -937.27 Thousand -138.13 Thousand
Common Stock - - -
Retained Earnings -14.06 Million -992.27 Thousand -138.13 Thousand
Accumulated other comprehensive income - - -55 Thousand
Common Stock Equity 3.43 Million -937.27 Thousand -138.13 Thousand
Capital Lease Obligation - - -
Total Investments - - -
Total Debt 101 Thousand 581.78 Thousand 119.39 Thousand
Net Debt 99.76 Thousand 580.36 Thousand 119.39 Thousand

Balance Sheet Charts